Showing results (2751-2760 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|February 24, 2009
Longitudinal health-related quality of life outcomes and related factors after pediatric SCTM Barrera, E Atenafu, K HancockBone Marrow Transplantation|February 24, 2009
Cancer stem cells: relevance to SCTT Lin, R J Jones, W MatsuiBone Marrow Transplantation|February 24, 2009
A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCTM Jarden, M T Baadsgaard, D J Hovgaard, et al.Bone Marrow Transplantation|June 23, 2009
Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCTC Cable, M P Buzzeo, J D Schold, et al.Bone Marrow Transplantation|June 23, 2009
T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graftA N Dubinsky, R K Burt, R Martin, et al.Bone Marrow Transplantation|June 23, 2009
Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilizationG Tricot, M H Cottler-Fox, G CalandraBone Marrow Transplantation|June 23, 2009
Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimenR Beri, S Chunduri, K Sweiss, et al.Bone Marrow Transplantation|September 1, 1991
Candida infections in bone marrow transplant recipientsC Verfaillie, D Weisdorf, R Haake, et al.Bone Marrow Transplantation|September 1, 1991
Bone marrow transplantation activity in Europe 1990. European Group for Bone Marrow Transplantation (EBMT)A GratwohlBone Marrow Transplantation|September 1, 1991
Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapyR H Van der Jagt, F R Appelbaum, F B Petersen, et al.Pageof 993